Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Total Non-Current Liabilities (2020 - 2023)

Rapid Therapeutic Science Laboratories' Total Non-Current Liabilities history spans 3 years, with the latest figure at $2.4 million for Q2 2023.

  • For Q2 2023, Total Non-Current Liabilities changed N/A year-over-year to $2.4 million; the TTM value through Jun 2023 reached $2.4 million, changed N/A, while the annual FY2022 figure was $3.0 million, N/A changed from the prior year.
  • Total Non-Current Liabilities for Q2 2023 was $2.4 million at Rapid Therapeutic Science Laboratories, down from $2.5 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $3.0 million in Q4 2022 and bottomed at $1.2 million in Q3 2020.
  • The 3-year median for Total Non-Current Liabilities is $2.4 million (2023), against an average of $2.3 million.